Relation of nocturnal polyuria of the elderly to essential hypertension

Lancet

Volumn 355, Issue 9202, 2000, Pages 486-488

  McKeigue, Paul M ^a   Reynard, John M ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; DIURETIC AGENT; NITRIC OXIDE; SODIUM; VASOPRESSIN; VASOPRESSIN DERIVATIVE;

AGING; CIRCADIAN RHYTHM; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; HUMAN; NOCTURIA; PATHOGENESIS; POLYURIA; PRIORITY JOURNAL; SEIZURE; SHORT SURVEY; SODIUM URINE LEVEL;

EID: 0034606964     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)82039-5     Document Type: Note

References (40)

1. Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P. Urinary symptoms in the community: how bothersome are they? Br J Urol. 74:1994;551-555.
2. Pinnock C, Marshall VR. Troublesome lower urinary tract symptoms in the community: a prevalence study. Med J Aust. 167:1997;72-75.
3. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc. 40:1992;1217-1220.
4. Reynard JM, Yang Q, Donovan JL, et al. The ICS-'BPH' study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol. 82:1998;619-623.
5. Emberton M, Neal DE, Black N, et al. The effect of prostatectomy on symptom severity and quality of life. Br J Urol. 77:1996;233-247.
6. Lepor H, Machi G. Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology. 42:1993;36-40.
7. Asplund R. Mortality in the elderly in relation to nocturnal micturition. Br J Urol Int. 84:1999;297-301.
8. Saito M, Kondo A, Kato T, Yamada Y. Frequency-volume charts: comparison of frequency between elderly and adult patients. Br J Urol. 72:1993;38-41.
9. Carter PG, Cannon A, McConnell AA, Abrams P. Role of atrial natriuretic peptide in nocturnal polyuria in elderly males. Eur Urol. 36:1999;213-220.
10. Matthiesen TB, Rittig S, Mortensen JT, Djurhuus JC. Nocturia and polyuria in men referred with lower urinary tract symptoms, assessed using a 7-day frequency-volume chart. Br J Urol Int. 83:1999;1017-1022.
11. Matthiesen TB, Rittig S, Norgaard JP, Pedersen EB, Djurhuus JC. Nocturnal polyuria and natriuresis in male patients with nocturia and lower urinary tract symptoms. J Urol. 156:1996;1292-1299.
12. Fowler FJJ, Wennberg JE, Timothy RP, Barry MJ, Mulley AGJ, Hanley D. Symptom status and quality of life following prostatectomy. JAMA. 259:1988;3018-3022.
13. Kirkland JL, Lye M, Levy DW, Banerjee AK. Patterns of urine flow and electrolyte excretion in healthy elderly people. BMJ. 287:1983;1665-1667.
14. Wilcox CS, Aminoff MJ, Penn W. Basis of nocturnal polyuria in patients with autonomic failure. J Neurol Neurosurg Psychiatry. 37:1974;677-684.
15. Asplund R, Sundberg B, Bengtsson P. Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. Br J Urol Int. 83:1999;591-595.
16. Cannon A, Carter PG, McConnell AA, Abrams P. Desmopressin in the treatment of nocturnal polyuria in the male. Br J Urol Int. 84:1999;20-24.
17. British National Formulary. London: British Medical Association and Royal Pharmaceutical Society of Great Britain, September, 1999: 340.
18. Bulpitt CJ, Dollery CT, Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J. 38:1976;121-128.
19. Staessen J, Broughton PM, Fletcher AE, et al. The assessment of the relationship between blood pressure and sodium intake using wholeday, daytime and overnight urine collections. J Hypertens. 9:1991;1035-1040.
20. Fujii T, Uzu T, Nishimura M, et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis. 33:1999;29-35.
21. Pedersen PA, Johansen PB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol. 62:1988;145-147.
22. Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol. 81:1998;215-218.
23. Drummer C, Fiedler F, Konig A, Gerzer R. Urodilatin, a kidney-derived natriuretic factor, is excreted with a circadian rhythm and is stimulated by saline infusion in man. J Am Soc Nephrol. 1:1991;1109-1113.
24. Meyer M, Richter R, Brunkhorst R, et al. Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects. Am J Physiol. 271:1996;F489-F497.
25. Drummer C, Franck W, Heer M, Forssmann WG, Gerzer R, Goetz K. Postprandial natriuresis in humans: further evidence that urodilatin, not ANP, modulates sodium excretion. Am J Physiol. 270:1996;F301-F310.
26. Richards AM, Tonolo G, Fraser R, et al. Diurnal change in plasma atrial natriuretic peptide concentrations. Clin Sci. 73:1987;489-495.
27. Siragy HM, Johns RA, Peach MJ, Carey RM. Nitric oxide alters renal function and guanosine 3′,5′-cyclic monophosphate. Hypertension. 19:1992;775-779.
28. Kanno K, Hirata Y, Emori T, et al. L-arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol. 19:1992;619-625.
29. Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol. 274:1998;F914-F923.
30. Kentsch M, Ludwig D, Drummer C, Gerzer R, Muller-Esch G. Haemodynamic and renal effects of urodilatin in healthy volunteers. Eur J Clin Invest. 22:1992;319-325.
31. Dijkhorst-Oei LT, Koomans HA. Effects of a nitric oxide synthesis inhibitor on renal sodium handling and diluting capacity in humans. Nephrol Dialysis Transplant. 13:1998;587-593.
32. Carstens J, Jensen KT, Pedersen EB. Effect of urodilatin infusion on renal haemodynamics, tubular function and vasoactive hormones. Clin Sci. 92:1997;397-407.
33. Gerhard M, Roddy MA, Creager SJ, Creager MA. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension. 27:1996;849-853.
34. Campo C, Lahera V, Garcia-Robles R, et al. Aging abolishes the renal response to L-arginine infusion in essential hypertension. Kidney Int Suppl. 55:1996;S126-S128.
35. Lyons D, Roy S, Patel M, Benjamin N, Swift CG. Impaired nitric oxide-mediated vasodilatation and total body nitric oxide production in healthy old age. Clin Sci. 93:1997;519-525.
36. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet. 349:1997;837-842.
37. Williams G, Donaldson RM. Nifedipine and nocturia. Lancet. i:1986;738.
38. Debruyne FM, Witjes WP, Fitzpatrick J, Kirby R, Kirk D, Prezioso D. The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. Eur Urol. 30:1996;369-376.
39. Rittig S, Knudsen UB, Norgaard JP, Gregersen H, Pedersen EB, Djurhuus JC. Diurnal variation of plasma atrial natriuretic peptide in normals and patients with enuresis nocturna. Scand J Clin Lab Invest. 51:1991;209-217.
40. Robson WL, Norgaard JP, Leung AK. Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr. 155:1996;959-962.